A macrolide antibiotic that acts as a specific inhibitor of vacuolar-type H+-ATPase. Useful in distinguishing among different types of ATPases.
Seeking published researchers utilizing our Bafilomycin A1 product? Hit the hot link for the full paper.
1. IFN-β Mediates Suppression of IL-12p40 in Human Dendritic Cells following Infection with Virulent Francisella tularensis, Timothy J. Bauler, Jennifer C. Chase, et al, Aug 2011; 187: 1845 - 1855.
2. Identification of PTP as an autophagic phosphatase, Katie R. Martin, Yong Xu, et al, Mar 2011; 124: 812 - 819.
3. The Early Phagosomal Stage of Francisella tularensis Determines Optimal Phagosomal Escape and Francisella Pathogenicity Island Protein Expression, Audrey Chong, Tara D. Wehrly, et al, Dec 2008; 76: 5488 - 5499.
4. V-ATPase expression during development of Artemia franciscana embryos: potential role for proton gradients in anoxia signaling, Joseph A. Covi and Steven C. Hand, Jul 2005; 208: 2783 - 2798.
5. Post-endocytic Sorting of Calcitonin Receptor-like Receptor and Receptor Activity-modifying Protein 1, Graeme S. Cottrell, Benjamin Padilla, et al, Apr 2007; 282: 12260 - 12271.
| A.G. Scientific, Inc. | |
|---|---|
| Product Category | Biological Materials |
| Product Number | B-1183 |
| Product Name | Bafilomycin A1 |
